ArticleHLA2026
BeadWatch: Automated Longitudinal Quality Control Monitoring for Luminex Bead-Based Immunoassays in Histocompatibility Laboratories.
Article in HLA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Luminex bead-based immunoassays are central to HLA antibody testing in histocompatibility laboratories, yet QC monitoring remains largely manual. Although ISO 15189, EFI and ASHI standards require statistical trend analysis, laboratories typically rely on spreadsheet tracking or periodic visual inspection; these approaches can detect gross run failures but are poorly suited to surfacing gradual trends in instrument, reagent and operator performance. We developed BeadWatch, an open-source automated QC dashboard application that reads directly from vendor databases, applies Levey-Jennings charts with optional I-MR views, and includes cross-instrument and cross-operator comparison dashboards and configurable alerting. BeadWatch currently supports OneLambda HLA Fusion and deploys as a single portable application with no installation steps. Single-site deployment in our laboratory ingested approximately 20 years of historical data, revealing instrument lifecycle trajectories and a step change in instrument MFI following a platform transition-patterns consistent with known instrument behaviour but not previously documented. During prospective monitoring, an automated alert identified a pipetting error before the responsible operator had independently recognised the issue. BeadWatch is freely available at https://github.com/oxfordgenes/BeadWatch.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.